Modern Diagnostic IPO Subscription Day 1

Here, the Modern Diagnostic IPO launched on 31st December 2025. Bidding for the issue will close today, 7th January 2026. The primary aim of the Modern Diagnostic IPO is to raise ₹36.89 crores from the market. Also, the Modern Diagnostic IPO has received an impressive level of subscription, indicating that the shares will be listed at an impeccable premium. Scroll down to check the Modern Diagnostic IPO subscription and details. 

Modern Diagnostic IPO Details 

The price band for Riddhi Display Equipment’s IPO has been set at ₹85 to ₹90 per share, and a total of 40,99,200 shares are being issued. Let’s segregate the share quota fixed for different categories of investors. 

Modern Diagnostic IPO Subscription Status

As of now, the Modern Diagnostic IPO has been subscribed to 0.80 times. Of these, 0.96 times are subscribed by retail investors, 1.50 times by non-institutional investors, and 0.00 times by QII (Qualified Institutional Investors).  

The healthy subscription status indicates that investors are expecting higher returns at the time of Modern Diagnostic’s IPO listing on 7th January 2026. Modern Diagnostic also has a positive outlook behind the fresh issue of 0.41 crore shares, which will raise around Rs 36.89 crores.

Modern Diagnostic IPO GMP Today

We know that higher subscription levels drive grey-market premiums for IPOs. Let’s explore the Modern Diagnostic IPO GMP for 31st December 2025. 

The grey market premium for this IPO has surged to 11.11% or Rs 10.00 per share. It indicates that the estimated listing price per share is Rs 100.00. Numerous factors played a pivotal role in this jump in the GMP of Riddhi Display Equipment’s IPO. These include higher subscription rates, favourable market sentiment, and investors’ positive attitude towards IPOs. 

About Modern Diagnostic Ltd.

Modern Diagnostic & Research Centre was established in 1985. Modern Diagnostic & Research Centre Limited (MDRC) is a diagnostic chain in India, offering a comprehensive range of pathology and radiology services. The company provides reliable diagnostic tests, home specimen collection, online reports, and customised test packages for institutional customers and patients, tailored to their specific needs. The company operates 21 centres (18 labs, three diagnostic centres) across eight states, offering diagnostic services such as ultrasound, CT, MRI, X-ray, ECG, PFT, and specialised labs for heart and neuro care. The company has been providing services such as Pathology, Radiology and Home sample collection. 

Modern Diagnostic Limited Financials

The company’s financial analysis is essential before applying for the Modern Diagnostic IPO. Look at the table to learn about Modern Diagnostic Limited’s financials. 

Explanation

Modern Diagnostic & Research Centre Limited’s revenue increased by 15% from ₹68.67 crores in March 2024 to ₹78.80 crores in March 2025. Moreover, the company’s PAT increased by 55% from ₹5.79 crores in March 2024 to ₹8.97 crores in March 2025.

Technical Indicators

Several technical indicators are available to assess a company’s potential to deliver returns. Use the parameters mentioned below to analyse the technical aspects of the Modern Diagnostic IPO.

Modern Diagnostic IPO Listing Expectations

Modern Diagnostic IPO Highlights: IPO allotment is still pending, as the bid will close today. However, given the current GMP or market sentiment, it is reasonable to expect higher listing gains for the share. A jump of 11.11% in Yash Highlight GMP suggests the estimated listing price per share will be around Rs 100.

It will provide higher listing gains to investors who applied for this IPO. Also, the financial fundamentals of this business made it the experts’ top long-term recommendation. 

Modern Diagnostic IPO Dates

Note: IPO GMP is volatile and depends on market sentiment. Hence, one should conduct their research before investing in it.

Recent Articles

Icodex Publishing Solutions IPO GMP: Day 1 IPO Live Updates

Bluestone Jewellery IPO GMP: Day 1 IPO Live Updates

Highway Infrastructure IPO Listing Preview: What to Expect Now in 2025?

Concord Biotech Q1 Results FY26: Q1 PAT Falls 26.07% to ₹44.06 Crore; Revenue Down 5.47% YoY

Action Construction Equipment Q1 Results FY26: Q1 PAT Rises 16.08% to ₹97.72 Crore; Revenue Down 11.19% YoY

Sawaliya Foods Products IPO Allotment Status Check Online: GMP, Subscription, Price, and More

Modern Diagnostic IPO Allotment Status Check Online: GMP, Subscription, Price, and More

Mahendra Realtors IPO GMP & Review: Apply or Avoid?

Regaal Resources IPO GMP & Review: Apply or Avoid?

Icodex Publishing Solutions IPO GMP & Review: Apply or Avoid?